suramin has been researched along with thalidomide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Catalano, A; Procopio, A; Robuffo, I; Romano, M; Strizzi, L | 1 |
| Libutti, SK; Zogakis, TG | 1 |
| Cavaletti, G; Marmiroli, P | 1 |
| Takano, S | 1 |
3 review(s) available for suramin and thalidomide
| Article | Year |
|---|---|
General aspects of anti-angiogenesis and cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies; Clinical Trials as Topic; Collagen; Cyclohexanes; Endostatins; Endothelial Growth Factors; Fatty Acids, Unsaturated; Humans; Interleukin-12; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Receptors, Vitronectin; RNA, Catalytic; Sesquiterpenes; Suramin; Thalidomide; Triazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Chemotherapy-induced peripheral neurotoxicity.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Epothilones; Humans; Neoplasms; Neuroprotective Agents; Organoplatinum Compounds; Peripheral Nervous System Diseases; Protease Inhibitors; Suramin; Taxoids; Thalidomide | 2004 |
[Anti-angiogenesis treatment for brain tumors--present and future].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Depression, Chemical; Fibroblast Growth Factors; Glioma; Humans; Hydroxamic Acids; Metalloproteases; Neovascularization, Pathologic; Receptors, Fibroblast Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinoids; Suramin; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2005 |
4 other study(ies) available for suramin and thalidomide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
Topics: Amino Acid Chloromethyl Ketones; Aminopeptidases; Angiogenesis Inhibitors; Apoptosis; Caspase 3; Caspases; Cell Division; Cell Survival; Collagen; Cyclohexanes; Cysteine Proteinase Inhibitors; Endostatins; Fatty Acids, Unsaturated; Genes, bcl-2; Humans; Mesothelioma; Metalloendopeptidases; Oligodeoxyribonucleotides, Antisense; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Suramin; Telomerase; Thalidomide; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2001 |